Trials / Completed
CompletedNCT04558567
Vogelxo(R) ABPM Study in Hypogandal Men
A Phase 4, Open-Label, Single-Arm Study to Evaluate the Effects of Vogelxo(R) on 24-hour Ambulatory Blood Pressure Monitoring in Hypogonadal Men Using Therapeutic Testosterone Replacement Therapy
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 122 (actual)
- Sponsor
- Upsher-Smith Laboratories · Industry
- Sex
- Male
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Not accepted
Summary
A Phase 4 ABPM study in Hypogonadal Men
Detailed description
A single-arm, open-label, uncontrolled study consisting of a 4-week screening phase, 4-week titration phase, and 16-week treatment phase.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Vogelxo | 50mg (1 tube, 5g gel) to 100mg (2 tubes, 10g gel) |
Timeline
- Start date
- 2020-08-28
- Primary completion
- 2023-12-12
- Completion
- 2024-01-11
- First posted
- 2020-09-22
- Last updated
- 2024-10-18
Locations
7 sites across 1 country: United States
Regulatory
- FDA-regulated drug study
Source: ClinicalTrials.gov record NCT04558567. Inclusion in this directory is not an endorsement.